C-reactive protein response induced by fungal infections. 1984

I Kostiala

Serial determinations of C-reactive protein (CRP) were performed by single radial immunodiffusion in four groups of patients with fungal disease in order to determine its use as an aid to diagnosis. Elevated values (17-284 mg/l) of CRP were seen in 13 patients with fungal septicaemia before and/or within a few days after the first positive blood culture. C-reactive protein was not elevated in two patients with transient fungaemia. In 76 per cent (25/33) of deep-seated fungal infections in patients with malignant disorders of the blood CRP increased to 104-380 mg/l. In the remainder values of 36-92 mg/l were seen. In 37 per cent (19/51) of episodes of acute uncomplicated fungal stomatitis in patients with malignant disorders of the blood CRP rose to 110-320 mg/l. C-reactive protein was not found to be raised from the normal value (less than or equal to 6 mg/l) in 6 per cent of the episodes; in the rest, values below 100 mg/l were seen. CRP in 23 patients with acute fungal stomatitis but who were not immunocompromised remained normal. Thus, with regard to its ability to induce high (greater than 100 mg/l) CRP values, deep-seated fungal disease would seem to resemble bacterial rather than viral infection.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002180 Candidiasis, Oral Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed) Moniliasis, Oral,Thrush,Candidiases, Oral,Moniliases, Oral,Oral Candidiases,Oral Candidiasis,Oral Moniliases,Oral Moniliasis
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease

Related Publications

I Kostiala
July 1998, Biulleten' eksperimental'noi biologii i meditsiny,
I Kostiala
March 1985, Indian pediatrics,
I Kostiala
January 1981, Journal of medical virology,
I Kostiala
August 1990, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
I Kostiala
July 1985, The Journal of pediatrics,
I Kostiala
August 1959, Bollettino della Societa italiana di biologia sperimentale,
I Kostiala
January 2005, The British journal of general practice : the journal of the Royal College of General Practitioners,
I Kostiala
April 2000, Ugeskrift for laeger,
I Kostiala
March 1984, Archives francaises de pediatrie,
Copied contents to your clipboard!